Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
-14.42x63.1x0.69x6446.99x-18.43x-13.91x-.--% 12.5B
41.47x6.5x2.02x9.67x34.91x35.61x0.03% 42.98B
15.59x3.77x0.2x5.55x12.22x13.35x1.92% 39.24B
-51.87x90.58x0.89x17.31x-57.69x-57.86x-.--% 30.07B
-17.46x1.05x6.12x4.3x-8.04x-6.31x-.--% 21.88B
27.73x2.6x0.68x5.41x15.05x18.82x-.--% 18.25B
21.68x2.5x-1.13x4.07x13.29x15.17x-.--% 16.03B
-316.87x11.38x6.48x26.28x1446.95x-317.41x-.--% 12.97B
-164.89x18.21x-1.91x40.26x-159.9x-145.87x-.--% 11.76B
13.48x3.47x1.34x3.75x8.89x10x-.--% 10.71B
-88.15x16.88x1.45x6.51x-97.25x-67.12x-.--% 10.2B
-32.77x - 1x - - - - 8.63B
-215.25x16.96x2.48x19.27x343.19x-437.09x-.--% 8.06B
-7.39x - -0.24x - -6.52x-6.33x-.--% 7.86B
-15.93x14.34x-0x15.21x-21.63x-15.24x-.--% 7.71B
-17.2x7.62x6.49x484.94x-14.6x-14.99x-.--% 7.7B
32.82x6.24x0.69x9.48x23.88x24.58x0.26% 7.59B
-9.31x-29.81x6.9x74.85x-10.07x-9.68x-.--% 7.4B
-22117.65x45.82x222.81x116.98x-1748x-1182.58x - 7.02B
Average -1,206.13x 16.54x 13.53x 428.87x -13.54x -119.83x 0.13% 15.19B
Weighted average by Cap. -565.08x 18.66x 7.09x 324.82x 23.53x -63.62x 0.29%
Bio Therapeutic Drugs
SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW